X-396 is a compound that functions as an inhibitor of anaplastic lymphoma kinase (ALK) and is noted for its ability to cross the blood-brain barrier. It is used as an active pharmaceutical ingredient in research and manufacturing settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing X-396?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
BQ-123
pharmaceutical raw material
[4-(hydroxymethyl)phenoxymethyl]polystyrene
pharmaceutical raw material
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[[4,4-difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-, cyclic (1→2)-ether,
pharmaceutical raw material
6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-(4-methylpiperazine-1-carbonyl)phenyl]pyridazine-3-carboxamide
ONPGOSVDVDPBCY-CQSZACIVSA-N
C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=CC(=NN=C2N)C(=O)NC3=CC=C(C=C3)C(=O)N4CCN(CC4)C
Sourcing X-396?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.